Arabic Arabic English English French French German German
dark

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery, announced that the U.S. Food and Drug Administration granted it Investigational Device Exemption to start a pivotal trial with MINIjectTM. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada’s National Research Council

Next Post

NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy

Related Posts
Total
0
Share